OCALIVA® (obeticholic acid) product information is for informational purposes only and not intended as promotion
Guidelines and Presentations
Select a resource below to view more information on clinical practice guidelines, our congress presentations, research and grant opportunities.
PBC: 2018 AASLD PRACTICE GUIDANCEVIEW GUIDANCE >
PBC: 2021 AASLD PRACTICE GUIDANCE UPDATEVIEW GUIDANCE >
INTERCEPT CONGRESS PRESENTATIONSDOWNLOAD PDF >
Request an MSL Visit
If you would like a visit from one of our medical science liaisons (MSL), send an email to firstname.lastname@example.org. Please include your full name, city, state/region and country where you practice (so that we can inform the MSL in your area), the best way to reach you (email and phone number), and the topic of discussion.
Investigator Initiated Research
We support independent, unsolicited research related to progressive non-viral liver diseases. For questions, or to submit a proposal for consideration, email IIR@interceptpharma.com.
Medical Educational Grants
Educational grants may be awarded to academic centers, hospitals, medical societies, professional associations or governmental agencies that sponsor and develop educational programs designed to meet the needs of healthcare professionals, researchers/scientists and patients.
We are a company rooted in the pursuit of effective treatments for patients with non-viral liver diseases. Learn more about our current clinical trials.